Optometry

Latest News


CME Content


Femtosecond lasers are gaining attention in the ophthalmic arena because of their ability to bring the precision of refractive surgery to cataract removal and IOL implantation.

Corneal collagen crosslinking is an effective treatment for improving uncorrected distance visual acuity, corrected distance visual acuity, and average and maximum K values.

Throughout his career, Robert H. Osher, MD, has been drawing large numbers of attendees at the major ophthalmic conferences to his presentations.

Simultaneous topography-guided partial PRK with cornea collagen crosslinking offers a safe and effective approach for normalizing the cornea and enhancing visual function in eyes with ectatic conditions.

All phakic IOLs provide excellent predictability and efficacy along with the benefit of rapid visual recovery, but the posterior and anterior chamber models each have their own pros and cons.

A proprietary fluorescein sodium and lissamine green dye combination has shown favorable results for evaluating the ocular surface.

While U.S. ophthalmologists continue to await FDA approval of the dual-optic accommodating IOL, accumulating data from a number of investigations are providing evidence about the long-term performance of this novel presbyopia-correcting implant technology.

In young patients who present with low-to-moderate myopia, minimal astigmatism, and excellent optics, there is no doubt that wavefront-guided LASIK with femtosecond laser flap creation is the refractive surgery procedure of choice.

Dog bite injuries frequently affect the periocular area, and clinicians should be familiar with the clinical examination, as well as the surgical and medical management paths to take in such cases.

Local therapy with intravitreal sustained-release implants may have a place in the management of ocular infectious and inflammatory diseases, especially when the benefits are weighed against those involved with systemic therapy for patients.

A rebate Genentech offers large-volume purchasers of its ranibizumab has stirred debate over the propriety of rewarding physicians for treating their patients with expensive drugs.

Implantable lenses may be a viable option for vision correction in patients with high myopia, and in those who have thin corneas or conditions that might predispose them to complications with LASIK.